Introduction: Osteoarthritis (OA) represents an increasing health issue worldwide. Regenerative medicine (RM) has raised the hope for introducing revolutionary therapies in clinical practice. Detection of autologus cell sources can improve accessibility to RM strategies. Objectives: To assess the presence and biological potential of mesehchymal stem cells in three tissues (subchondral bone, synovial layer, periarticular adipose tissue) in late stages osteoarthritic patients. Material and Methods: Samples were collected from subjects undergoing total knee replacement (TKR). MSCs were isolated and cultured in complete alpha MEM with beta FGF. Cell morphology and growth potential was assessed. Flow cytometry was used for detection of several r...
Introduction: Mesenchymal stem cell is a promising therapeutic option in orthopedic filed and regene...
Osteoarthritis (OA) is a chronic, progressive joint disorder affecting 8.5 million people in the UK ...
Osteoarthritis (OA) is a chronic, progressive joint disorder affecting 8.5 million people in the UK ...
Introduction: Osteoarthritis (OA) represents an increasing health issue worldwide. Regenerative medi...
Introduction: Osteoarthritis (OA) represents an increasing health issue worldwide. Regenerative medi...
The demand for treatment strategies for damaged musculoskeletal tissue is continuously growing, espe...
Contains fulltext : 52232.pdf (publisher's version ) (Closed access)Osteoarthritis...
Introduction: Mesenchymal stem cells (MSCs) can be isolated from different tissue sources, and show ...
Osteophytes form through the process of chondroid metamorphosis of fibrous tissue followed by endoch...
Previous studies have identified stem cell populations in articular cartilage using colony forming a...
Previous studies have identified stem cell populations in articular cartilage using colony forming a...
Previous studies have identified stem cell populations in articular cartilage using colony forming a...
Osteophytes are the most remarkable and consistently distinct feature of osteoarthritis (OA). Their ...
Osteoarthritis is characterized by loss of articular cartilage also due to reduced chondrogenic acti...
OBJECTIVE: To characterize mesenchymal stem cells (MSCs) from human synovial membrane (SM). METHODS:...
Introduction: Mesenchymal stem cell is a promising therapeutic option in orthopedic filed and regene...
Osteoarthritis (OA) is a chronic, progressive joint disorder affecting 8.5 million people in the UK ...
Osteoarthritis (OA) is a chronic, progressive joint disorder affecting 8.5 million people in the UK ...
Introduction: Osteoarthritis (OA) represents an increasing health issue worldwide. Regenerative medi...
Introduction: Osteoarthritis (OA) represents an increasing health issue worldwide. Regenerative medi...
The demand for treatment strategies for damaged musculoskeletal tissue is continuously growing, espe...
Contains fulltext : 52232.pdf (publisher's version ) (Closed access)Osteoarthritis...
Introduction: Mesenchymal stem cells (MSCs) can be isolated from different tissue sources, and show ...
Osteophytes form through the process of chondroid metamorphosis of fibrous tissue followed by endoch...
Previous studies have identified stem cell populations in articular cartilage using colony forming a...
Previous studies have identified stem cell populations in articular cartilage using colony forming a...
Previous studies have identified stem cell populations in articular cartilage using colony forming a...
Osteophytes are the most remarkable and consistently distinct feature of osteoarthritis (OA). Their ...
Osteoarthritis is characterized by loss of articular cartilage also due to reduced chondrogenic acti...
OBJECTIVE: To characterize mesenchymal stem cells (MSCs) from human synovial membrane (SM). METHODS:...
Introduction: Mesenchymal stem cell is a promising therapeutic option in orthopedic filed and regene...
Osteoarthritis (OA) is a chronic, progressive joint disorder affecting 8.5 million people in the UK ...
Osteoarthritis (OA) is a chronic, progressive joint disorder affecting 8.5 million people in the UK ...